emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Allergan / Inamed

No EMAT : 21070
Announced Date : 15/11/2005
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Allergan

Target : Inamed
Country : United States
Sector of activity :
  • Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
  • Medical Equipment > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Implants or Prostheses Manufacturers
Business Description :
Founded in 1974, Inamed Corp. develops and manufactures healthcare products. > Its products include: breast implants for aesthetic augmentation and for reconstructive surgery; a range of dermal...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : *
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
  • Number of EMAT Reports / sub-sector « Medical Implants or Prostheses Manufacturers » = 63
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
18/05/2005 L'Oreal SkinCeuticals United States * 21060
28/07/2009 Benefit SpA Mirato Italy *** 21057

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report